MYBB_HUMAN - dbPTM
MYBB_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MYBB_HUMAN
UniProt AC P10244
Protein Name Myb-related protein B
Gene Name MYBL2
Organism Homo sapiens (Human).
Sequence Length 700
Subcellular Localization Nucleus.
Protein Description Transcription factor involved in the regulation of cell survival, proliferation, and differentiation. Transactivates the expression of the CLU gene..
Protein Sequence MSRRTRCEDLDELHYQDTDSDVPEQRDSKCKVKWTHEEDEQLRALVRQFGQQDWKFLASHFPNRTDQQCQYRWLRVLNPDLVKGPWTKEEDQKVIELVKKYGTKQWTLIAKHLKGRLGKQCRERWHNHLNPEVKKSCWTEEEDRIICEAHKVLGNRWAEIAKMLPGRTDNAVKNHWNSTIKRKVDTGGFLSESKDCKPPVYLLLELEDKDGLQSAQPTEGQGSLLTNWPSVPPTIKEEENSEEELAAATTSKEQEPIGTDLDAVRTPEPLEEFPKREDQEGSPPETSLPYKWVVEAANLLIPAVGSSLSEALDLIESDPDAWCDLSKFDLPEEPSAEDSINNSLVQLQASHQQQVLPPRQPSALVPSVTEYRLDGHTISDLSRSSRGELIPISPSTEVGGSGIGTPPSVLKRQRKRRVALSPVTENSTSLSFLDSCNSLTPKSTPVKTLPFSPSQFLNFWNKQDTLELESPSLTSTPVCSQKVVVTTPLHRDKTPLHQKHAAFVTPDQKYSMDNTPHTPTPFKNALEKYGPLKPLPQTPHLEEDLKEVLRSEAGIELIIEDDIRPEKQKRKPGLRRSPIKKVRKSLALDIVDEDVKLMMSTLPKSLSLPTTAPSNSSSLTLSGIKEDNSLLNQGFLQAKPEKAAVAQKPRSHFTTPAPMSSAWKTVACGGTRDQLFMQEKARQLLGRLKPSHTSRTLILS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MSRRTRCEDLDE
---CCCCCCCCCHHH
38.2628111955
15PhosphorylationEDLDELHYQDTDSDV
CCHHHHHCCCCCCCC
22.2530576142
18PhosphorylationDELHYQDTDSDVPEQ
HHHHCCCCCCCCCCH
23.1323898821
20PhosphorylationLHYQDTDSDVPEQRD
HHCCCCCCCCCCHHC
42.4722617229
28PhosphorylationDVPEQRDSKCKVKWT
CCCCHHCCCCCCEEC
41.9921498570
33UbiquitinationRDSKCKVKWTHEEDE
HCCCCCCEECCCHHH
31.6929967540
93SumoylationWTKEEDQKVIELVKK
CCHHHHHHHHHHHHH
58.46-
93SumoylationWTKEEDQKVIELVKK
CCHHHHHHHHHHHHH
58.46-
104SumoylationLVKKYGTKQWTLIAK
HHHHHCCHHHHHHHH
39.20-
104SumoylationLVKKYGTKQWTLIAK
HHHHHCCHHHHHHHH
39.2028112733
110UbiquitinationTKQWTLIAKHLKGRL
CHHHHHHHHHHHHHH
9.0529967540
127UbiquitinationQCRERWHNHLNPEVK
HHHHHHHHHCCHHHH
34.0929967540
134SumoylationNHLNPEVKKSCWTEE
HHCCHHHHHHCCCHH
36.99-
134SumoylationNHLNPEVKKSCWTEE
HHCCHHHHHHCCCHH
36.99-
134UbiquitinationNHLNPEVKKSCWTEE
HHCCHHHHHHCCCHH
36.9929967540
135UbiquitinationHLNPEVKKSCWTEEE
HCCHHHHHHCCCHHH
56.90-
136PhosphorylationLNPEVKKSCWTEEED
CCHHHHHHCCCHHHH
14.7925404012
138UbiquitinationPEVKKSCWTEEEDRI
HHHHHHCCCHHHHHH
17.5929967540
149UbiquitinationEDRIICEAHKVLGNR
HHHHHHHHHHHHHHH
11.9129967540
151UbiquitinationRIICEAHKVLGNRWA
HHHHHHHHHHHHHHH
46.3229967540
157UbiquitinationHKVLGNRWAEIAKML
HHHHHHHHHHHHHHC
11.4029967540
159UbiquitinationVLGNRWAEIAKMLPG
HHHHHHHHHHHHCCC
36.2029967540
162UbiquitinationNRWAEIAKMLPGRTD
HHHHHHHHHCCCCCC
46.7829967540
168PhosphorylationAKMLPGRTDNAVKNH
HHHCCCCCCHHHHHH
39.2526074081
173UbiquitinationGRTDNAVKNHWNSTI
CCCCHHHHHHHHHCH
40.4629967540
178PhosphorylationAVKNHWNSTIKRKVD
HHHHHHHHCHHCCCC
26.7325159151
181UbiquitinationNHWNSTIKRKVDTGG
HHHHHCHHCCCCCCC
46.3729967540
183UbiquitinationWNSTIKRKVDTGGFL
HHHCHHCCCCCCCCC
39.1929967540
194SumoylationGGFLSESKDCKPPVY
CCCCCCCCCCCCCEE
64.1928112733
197SumoylationLSESKDCKPPVYLLL
CCCCCCCCCCEEEEE
63.59-
197SumoylationLSESKDCKPPVYLLL
CCCCCCCCCCEEEEE
63.5928112733
234PhosphorylationNWPSVPPTIKEEENS
CCCCCCCCCCCCCCC
38.31-
236SumoylationPSVPPTIKEEENSEE
CCCCCCCCCCCCCHH
62.64-
241PhosphorylationTIKEEENSEEELAAA
CCCCCCCCHHHHHHH
50.0629255136
242PhosphorylationIKEEENSEEELAAAT
CCCCCCCHHHHHHHH
68.0532142685
249PhosphorylationEEELAAATTSKEQEP
HHHHHHHHCCCCCCC
27.2026074081
250PhosphorylationEELAAATTSKEQEPI
HHHHHHHCCCCCCCC
32.8326074081
251PhosphorylationELAAATTSKEQEPIG
HHHHHHCCCCCCCCC
29.8226074081
259PhosphorylationKEQEPIGTDLDAVRT
CCCCCCCCCCHHCCC
33.8222199227
266PhosphorylationTDLDAVRTPEPLEEF
CCCHHCCCCCCHHHC
25.9630266825
275SumoylationEPLEEFPKREDQEGS
CCHHHCCCCCCCCCC
73.9828112733
282PhosphorylationKREDQEGSPPETSLP
CCCCCCCCCCCCCCC
36.2123401153
286PhosphorylationQEGSPPETSLPYKWV
CCCCCCCCCCCHHHH
41.1423663014
287PhosphorylationEGSPPETSLPYKWVV
CCCCCCCCCCHHHHH
26.1929255136
290PhosphorylationPPETSLPYKWVVEAA
CCCCCCCHHHHHHHH
23.8323186163
362PhosphorylationVLPPRQPSALVPSVT
CCCCCCCCCCCCCEE
26.37-
384PhosphorylationTISDLSRSSRGELIP
CHHHCCCCCCCCEEE
22.4723090842
385PhosphorylationISDLSRSSRGELIPI
HHHCCCCCCCCEEEC
43.1023090842
387UbiquitinationDLSRSSRGELIPISP
HCCCCCCCCEEECCC
35.69-
393PhosphorylationRGELIPISPSTEVGG
CCCEEECCCCCCCCC
13.8823401153
395PhosphorylationELIPISPSTEVGGSG
CEEECCCCCCCCCCC
30.3430266825
396PhosphorylationLIPISPSTEVGGSGI
EEECCCCCCCCCCCC
37.7730266825
401PhosphorylationPSTEVGGSGIGTPPS
CCCCCCCCCCCCCHH
22.7022167270
405PhosphorylationVGGSGIGTPPSVLKR
CCCCCCCCCHHHHHH
30.0622167270
408PhosphorylationSGIGTPPSVLKRQRK
CCCCCCHHHHHHHHH
41.0822167270
411UbiquitinationGTPPSVLKRQRKRRV
CCCHHHHHHHHHCCE
44.31-
411SumoylationGTPPSVLKRQRKRRV
CCCHHHHHHHHHCCE
44.3128112733
421PhosphorylationRKRRVALSPVTENST
HHCCEEECCCCCCCC
13.9529255136
424PhosphorylationRVALSPVTENSTSLS
CEEECCCCCCCCCCH
32.6029255136
427PhosphorylationLSPVTENSTSLSFLD
ECCCCCCCCCCHHHH
17.0925850435
428PhosphorylationSPVTENSTSLSFLDS
CCCCCCCCCCHHHHH
45.3125850435
429PhosphorylationPVTENSTSLSFLDSC
CCCCCCCCCHHHHHC
23.1028464451
431PhosphorylationTENSTSLSFLDSCNS
CCCCCCCHHHHHCCC
24.4326074081
435PhosphorylationTSLSFLDSCNSLTPK
CCCHHHHHCCCCCCC
19.8329255136
438PhosphorylationSFLDSCNSLTPKSTP
HHHHHCCCCCCCCCC
37.6429255136
440PhosphorylationLDSCNSLTPKSTPVK
HHHCCCCCCCCCCCC
28.6129255136
443PhosphorylationCNSLTPKSTPVKTLP
CCCCCCCCCCCCCCC
38.86-
444PhosphorylationNSLTPKSTPVKTLPF
CCCCCCCCCCCCCCC
37.9210095772
447UbiquitinationTPKSTPVKTLPFSPS
CCCCCCCCCCCCCHH
45.61-
447SumoylationTPKSTPVKTLPFSPS
CCCCCCCCCCCCCHH
45.6128112733
448PhosphorylationPKSTPVKTLPFSPSQ
CCCCCCCCCCCCHHH
39.6422199227
452PhosphorylationPVKTLPFSPSQFLNF
CCCCCCCCHHHHHHH
23.0025159151
454PhosphorylationKTLPFSPSQFLNFWN
CCCCCCHHHHHHHHC
32.1628450419
465PhosphorylationNFWNKQDTLELESPS
HHHCCCCCEEECCCC
21.46-
470PhosphorylationQDTLELESPSLTSTP
CCCEEECCCCCCCCC
32.2029083192
472PhosphorylationTLELESPSLTSTPVC
CEEECCCCCCCCCCC
54.2629083192
474PhosphorylationELESPSLTSTPVCSQ
EECCCCCCCCCCCCC
34.5928348404
475PhosphorylationLESPSLTSTPVCSQK
ECCCCCCCCCCCCCE
35.6929083192
475UbiquitinationLESPSLTSTPVCSQK
ECCCCCCCCCCCCCE
35.6929967540
476PhosphorylationESPSLTSTPVCSQKV
CCCCCCCCCCCCCEE
17.9527050516
480PhosphorylationLTSTPVCSQKVVVTT
CCCCCCCCCEEEEEC
33.0229083192
482SumoylationSTPVCSQKVVVTTPL
CCCCCCCEEEEECCC
22.2428112733
485UbiquitinationVCSQKVVVTTPLHRD
CCCCEEEEECCCCCC
5.7429967540
486PhosphorylationCSQKVVVTTPLHRDK
CCCEEEEECCCCCCC
15.8730266825
487PhosphorylationSQKVVVTTPLHRDKT
CCEEEEECCCCCCCC
16.5530266825
494PhosphorylationTPLHRDKTPLHQKHA
CCCCCCCCCCCCCCE
35.0630576142
499UbiquitinationDKTPLHQKHAAFVTP
CCCCCCCCCEEEECC
25.1829967540
499SumoylationDKTPLHQKHAAFVTP
CCCCCCCCCEEEECC
25.1828112733
504UbiquitinationHQKHAAFVTPDQKYS
CCCCEEEECCCCCCC
6.9629967540
505PhosphorylationQKHAAFVTPDQKYSM
CCCEEEECCCCCCCC
18.0730266825
509SumoylationAFVTPDQKYSMDNTP
EEECCCCCCCCCCCC
46.82-
509SumoylationAFVTPDQKYSMDNTP
EEECCCCCCCCCCCC
46.8228112733
509UbiquitinationAFVTPDQKYSMDNTP
EEECCCCCCCCCCCC
46.8229967540
509AcetylationAFVTPDQKYSMDNTP
EEECCCCCCCCCCCC
46.82-
509UbiquitinationAFVTPDQKYSMDNTP
EEECCCCCCCCCCCC
46.82-
510PhosphorylationFVTPDQKYSMDNTPH
EECCCCCCCCCCCCC
12.0026074081
511PhosphorylationVTPDQKYSMDNTPHT
ECCCCCCCCCCCCCC
27.0526074081
515PhosphorylationQKYSMDNTPHTPTPF
CCCCCCCCCCCCCCC
16.5128450419
518PhosphorylationSMDNTPHTPTPFKNA
CCCCCCCCCCCCHHH
30.0225159151
520PhosphorylationDNTPHTPTPFKNALE
CCCCCCCCCCHHHHH
42.3822617229
522UbiquitinationTPHTPTPFKNALEKY
CCCCCCCCHHHHHHH
11.9529967540
523UbiquitinationPHTPTPFKNALEKYG
CCCCCCCHHHHHHHC
42.3829967540
523SumoylationPHTPTPFKNALEKYG
CCCCCCCHHHHHHHC
42.3828112733
528UbiquitinationPFKNALEKYGPLKPL
CCHHHHHHHCCCCCC
57.2529967540
529PhosphorylationFKNALEKYGPLKPLP
CHHHHHHHCCCCCCC
18.0123312004
533AcetylationLEKYGPLKPLPQTPH
HHHHCCCCCCCCCCC
47.8723749302
533UbiquitinationLEKYGPLKPLPQTPH
HHHHCCCCCCCCCCC
47.8729967540
533SumoylationLEKYGPLKPLPQTPH
HHHHCCCCCCCCCCC
47.8728112733
538PhosphorylationPLKPLPQTPHLEEDL
CCCCCCCCCCHHHHH
15.6725159151
546SumoylationPHLEEDLKEVLRSEA
CCHHHHHHHHHHHHH
59.09-
546SumoylationPHLEEDLKEVLRSEA
CCHHHHHHHHHHHHH
59.0928112733
546UbiquitinationPHLEEDLKEVLRSEA
CCHHHHHHHHHHHHH
59.0929967540
560UbiquitinationAGIELIIEDDIRPEK
HCEEEEECCCCCHHH
42.5129967540
577PhosphorylationRKPGLRRSPIKKVRK
CCCCCCCCHHHHHHH
25.2528112733
584UbiquitinationSPIKKVRKSLALDIV
CHHHHHHHHHHHHHC
53.4629967540
584SumoylationSPIKKVRKSLALDIV
CHHHHHHHHHHHHHC
53.4628112733
585PhosphorylationPIKKVRKSLALDIVD
HHHHHHHHHHHHHCC
14.3322199227
596SumoylationDIVDEDVKLMMSTLP
HHCCHHHHHHHHHCC
42.88-
596SumoylationDIVDEDVKLMMSTLP
HHCCHHHHHHHHHCC
42.8828112733
600PhosphorylationEDVKLMMSTLPKSLS
HHHHHHHHHCCCCCC
16.9020068231
601UbiquitinationDVKLMMSTLPKSLSL
HHHHHHHHCCCCCCC
29.2329967540
601PhosphorylationDVKLMMSTLPKSLSL
HHHHHHHHCCCCCCC
29.2320068231
615UbiquitinationLPTTAPSNSSSLTLS
CCCCCCCCCCCEEEE
44.8729967540
615AcetylationLPTTAPSNSSSLTLS
CCCCCCCCCCCEEEE
44.87-
624UbiquitinationSSLTLSGIKEDNSLL
CCEEEECHHHCCCHH
3.8729967540
625SumoylationSLTLSGIKEDNSLLN
CEEEECHHHCCCHHH
63.6428112733
625UbiquitinationSLTLSGIKEDNSLLN
CEEEECHHHCCCHHH
63.6429967540
629PhosphorylationSGIKEDNSLLNQGFL
ECHHHCCCHHHCCCC
46.7025159151
639SumoylationNQGFLQAKPEKAAVA
HCCCCCCCHHHHHHC
40.52-
639SumoylationNQGFLQAKPEKAAVA
HCCCCCCCHHHHHHC
40.5228112733
639UbiquitinationNQGFLQAKPEKAAVA
HCCCCCCCHHHHHHC
40.5229967540
639AcetylationNQGFLQAKPEKAAVA
HCCCCCCCHHHHHHC
40.5223236377
648UbiquitinationEKAAVAQKPRSHFTT
HHHHHCCCCHHHCCC
32.4329967540
648AcetylationEKAAVAQKPRSHFTT
HHHHHCCCCHHHCCC
32.4325953088
648SumoylationEKAAVAQKPRSHFTT
HHHHHCCCCHHHCCC
32.4328112733
654PhosphorylationQKPRSHFTTPAPMSS
CCCHHHCCCCCCCCC
26.8426074081
655PhosphorylationKPRSHFTTPAPMSSA
CCHHHCCCCCCCCCC
19.2626074081
660PhosphorylationFTTPAPMSSAWKTVA
CCCCCCCCCCCCCHH
18.8226074081
661PhosphorylationTTPAPMSSAWKTVAC
CCCCCCCCCCCCHHC
31.7126074081
693PhosphorylationGRLKPSHTSRTLILS
CCCCCCCCCCEEECC
25.00-
695MethylationLKPSHTSRTLILS--
CCCCCCCCEEECC--
34.41-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
18TPhosphorylationKinaseCSNK2A1P68400
GPS
440TPhosphorylationKinaseCDK2P24941
Uniprot
444TPhosphorylationKinaseCDK2P24941
Uniprot
487TPhosphorylationKinaseCDK2P24941
Uniprot
494TPhosphorylationKinaseCDK2P24941
Uniprot
520TPhosphorylationKinaseCDK2P24941
Uniprot
577SPhosphorylationKinaseCDK2P24941
Uniprot
-KUbiquitinationE3 ubiquitin ligaseSKP2Q13309
PMID:10871850
-KUbiquitinationE3 ubiquitin ligaseCDC34P49427
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
520TPhosphorylation

10095772

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MYBB_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ZN622_HUMANZNF622physical
12645566
CDN1C_HUMANCDKN1Cphysical
12947099
CBP_HUMANCREBBPgenetic
11423988
PARP1_HUMANPARP1physical
10744766
CCNA1_HUMANCCNA1physical
11264176
MYBB_HUMANMYBL2physical
10544265
CDK9_HUMANCDK9genetic
10656684
CCNT1_HUMANCCNT1genetic
10656684
CDK9_HUMANCDK9physical
10656684
LZTR1_HUMANLZTR1physical
20211142
TRI15_HUMANTRIM15physical
20211142
ZBTB9_HUMANZBTB9physical
20211142
LIN54_HUMANLIN54physical
17671431
LIN9_HUMANLIN9physical
17671431
LIN37_HUMANLIN37physical
17671431
RBBP4_HUMANRBBP4physical
17671431
RBL1_HUMANRBL1physical
17671431
LIN9_HUMANLIN9physical
17159899
FLNA_HUMANFLNAphysical
18548008
SPTA1_HUMANSPTA1physical
18548008
CLH1_HUMANCLTCphysical
18548008
SPTB2_HUMANSPTBN1physical
18548008
CLCA_HUMANCLTAphysical
18548008
LIN9_HUMANLIN9physical
18548008
UB2D4_HUMANUBE2D4physical
21988832
CCNF_HUMANCCNFphysical
25557911
PA24A_HUMANPLA2G4Aphysical
14769798
EPAS1_HUMANEPAS1physical
28394947

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MYBB_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241 AND THR-405, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-393, AND MASSSPECTROMETRY.
"Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.";
Bartsch O., Horstmann S., Toprak K., Klempnauer K.H., Ferrari S.;
Eur. J. Biochem. 260:384-391(1999).
Cited for: PHOSPHORYLATION AT THR-440; THR-444; THR-494; THR-520 AND SER-577.
"The cell-cycle regulated transcription factor B-Myb is phosphorylatedby cyclin A/Cdk2 at sites that enhance its transactivationproperties.";
Saville M.K., Watson R.J.;
Oncogene 17:2679-2689(1998).
Cited for: PHOSPHORYLATION AT THR-444; THR-487; THR-494 AND SER-577.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-266, AND MASSSPECTROMETRY.

TOP